Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CGTX: Cognition Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CGTX
The Story
CGTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-141.0%
Financially safe
Stretched
Debt / equity
0.02×
Interest coverage
-3295.5×
Current ratio
5.92×
Cognition Therapeutics, Inc.
CGTX
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Cognition Therapeutics, Inc.
CGTX
NASDAQ
·
USD
·
Closed
$0.89
−2.88%
$0.89
−$0.03 (2.88%)
52W Range
10th
pctl
Volume
0.27×
avg
Mkt Cap
79.62M
USD
P/E
-3.4
TTM
Div Yield
–
ann
52W Range
10th
pctl
Volume
0.27×
avg
Market Cap
79.62M
USD
P/E Ratio
-3.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings